Abstract | BACKGROUND: METHODS: A total of 150 type 2 diabetes patients aged 50 years and older were enrolled, including 50 patients with CRC and 100 patients without CRC. We measured Serum levels of sRAGE and interleukin-6(IL-6) using an enzyme-linked immunosorbent assay (ELISA). In addition, other clinical parameters were also measured during hospitalization. RESULTS:
Type 2 diabetes patients with CRC had higher triglyceride, total cholesterol, IL-6, and circulating sRAGE levels and lower use of medicines than type 2 diabetes patients without CRC. Circulating sRAGE was associated with an increased risk for CRC (OR = 2.289 for each SD increase in sRAGE, 95% CI = 1.037-5.051; P = 0.04) among Type 2 diabetes patients after adjustment for confounders. Furthermore, circulating sRAGE levels among type 2 diabetes patients were positively correlated with triglyceride (r = 0.377, P < 0.001), total cholesterol (r = 0.491, P < 0.001), and low-density lipoprotein cholesterol ( LDL-c)(r = 0.330, P < 0.001) levels; the homeostatic model assessment for insulin resistance(HOMA-IR)score (r = 0.194, P = 0.017); and fasting serum insulin (r = 0.167, P = 0.041) and IL-6 (r = 0.311, P < 0.001) concentrations. CONCLUSIONS:
|
Authors | Xiaohai Zhou, Ning Lin, Mingjie Zhang, Xiaoling Wang, Ye An, Qing Su, Peng Du, Bo Li, Hanbei Chen |
Journal | BMC endocrine disorders
(BMC Endocr Disord)
Vol. 20
Issue 1
Pg. 170
(Nov 13 2020)
ISSN: 1472-6823 [Electronic] England |
PMID | 33187505
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers
- Blood Glucose
- Receptor for Advanced Glycation End Products
- sRAGE protein, human
|
Topics |
- Aged
- Biomarkers
(blood)
- Blood Glucose
(analysis)
- Colorectal Neoplasms
(blood, diagnosis, etiology)
- Cross-Sectional Studies
- Diabetes Mellitus, Type 2
(complications)
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Prognosis
- Receptor for Advanced Glycation End Products
(blood)
|